CAPTRUST Financial Advisors’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-439
| Closed | -$20K | – | 4259 |
|
|
2022
Q2 | $20K | Hold |
439
| – | – | ﹤0.01% | 3387 |
|
|
2022
Q1 | $22K | Buy |
439
+373
| +565% | +$18.7K | ﹤0.01% | 3333 |
|
|
2021
Q4 | $3K | Buy |
66
+15
| +29% | +$682 | ﹤0.01% | 4321 |
|
|
2021
Q3 | $3K | Hold |
51
| – | – | ﹤0.01% | 4171 |
|
|
2021
Q2 | $2K | Buy |
51
+9
| +21% | +$353 | ﹤0.01% | 4223 |
|
|
2021
Q1 | $2K | Buy |
42
+17
| +68% | +$810 | ﹤0.01% | 4093 |
|
|
2020
Q4 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 3337 |
|